114 related articles for article (PubMed ID: 3753907)
1. Inhibition of thromboxane biosynthesis in splanchnic ischemia shock.
Oei HH; Zoganas HC; Sakane Y; Robson RD; Glenn TM
Circ Shock; 1986; 18(2):95-106. PubMed ID: 3753907
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of G 619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, in splanchnic artery occlusion shock.
Squadrito F; Altavilla D; Zingarelli B; Ioculano MP; Campo GM; Calapai G; Saitta A; Urna G; Sardella A; Spignoli G
J Cardiovasc Pharmacol; 1992 Jan; 19(1):115-9. PubMed ID: 1375677
[TBL] [Abstract][Full Text] [Related]
3. [Cardio- and hemodynamics of dogs during the development of postischemic shock reaction].
Sagach VF; Dmitrieva AV
Fiziol Zh (1978); 1989; 35(4):9-15. PubMed ID: 2792447
[TBL] [Abstract][Full Text] [Related]
4. The effect of a thromboxane synthetase inhibitor, dazoxiben, and acetylsalicylic acid on platelet function and prostaglandin metabolism.
Dale J; Thaulow E; Myhre E; Parry J
Thromb Haemost; 1983 Oct; 50(3):703-6. PubMed ID: 6689091
[TBL] [Abstract][Full Text] [Related]
5. [Effect of dazoxiben on cerebrovascular resistance in rabbits].
Rui YC; Sun DX; Long K
Zhongguo Yao Li Xue Bao; 1989 Jul; 10(4):342-5. PubMed ID: 2624120
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of endogenous thromboxane synthesis by exogenous prostacyclin during endotoxemia in conscious sheep.
Flynn JT; Demling RH
Adv Shock Res; 1982; 7():199-207. PubMed ID: 6753534
[TBL] [Abstract][Full Text] [Related]
7. Effect of the thromboxane synthetase inhibitor UK-37,248 (dazoxiben) upon platelet aggregation, coronary artery thrombosis and vascular reactivity.
Schumacher WA; Lucchesi BR
J Pharmacol Exp Ther; 1983 Dec; 227(3):790-6. PubMed ID: 6418881
[TBL] [Abstract][Full Text] [Related]
8. Intestinal and arterial plasma thromboxane and prostacyclin levels in shock: effects of indomethacin.
Mózes T; Wieszt E
J Surg Res; 1989 Dec; 47(6):482-6. PubMed ID: 2511379
[TBL] [Abstract][Full Text] [Related]
9. Effects of a specific thromboxane synthetase inhibitor in equine endotoxaemia.
Semrad SD; Moore JN
Res Vet Sci; 1987 Sep; 43(2):137-42. PubMed ID: 3317581
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of BAY u3405, a novel thromboxane A2 receptor antagonist, in splanchnic artery occlusion shock.
Canale P; Squadrito F; Altavilla D; Ioculano M; Campo GM; Squadrito G; Urna G; Sardella A; Caputi AP
Pharmacology; 1994 Dec; 49(6):376-85. PubMed ID: 7878075
[TBL] [Abstract][Full Text] [Related]
11. On the mechanism of thrombolytic action of thromboxane synthetase inhibitors.
Korbut R; Dembińska-Kieć A; Swies J; Zmuda A; Gryglewski RJ
Thromb Haemost; 1987 Oct; 58(3):827-30. PubMed ID: 3324381
[TBL] [Abstract][Full Text] [Related]
12. Role of eicosanoids in the postischemic shock development.
Zhukova AV; Sagach VF
Pol J Pharmacol; 1996; 48(1):23-9. PubMed ID: 9112624
[TBL] [Abstract][Full Text] [Related]
13. Effect of selective inhibition of thromboxane synthesis on renal function in diabetic nephropathy.
Kontessis PS; Jones SL; Barrow SE; Stratton PD; Alessandrini P; De Cosmo S; Ritter JM; Viberti GC
J Lab Clin Med; 1993 Mar; 121(3):415-23. PubMed ID: 8445289
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of thromboxane formation prevents endotoxin-induced renal fibrin deposition in jaundiced rats.
Westwick J; Fletcher MS; Kakkar VV
Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():83-91. PubMed ID: 6221642
[No Abstract] [Full Text] [Related]
15. Depression of left ventricular performance during canine splanchnic artery occlusion shock.
Nightingale LM; Tambolini WP; Kish P; Weber P; Goldfarb RD
Circ Shock; 1984; 14(2):93-106. PubMed ID: 6509727
[TBL] [Abstract][Full Text] [Related]
16. Indomethacin, but not dazoxiben, reduced lung fluid filtration after E. coli infusion.
Winn R; Enderson B; Price S; Rice CL
J Appl Physiol (1985); 1988 Jun; 64(6):2468-73. PubMed ID: 3042734
[TBL] [Abstract][Full Text] [Related]
17. Effects of selective thromboxane synthetase inhibitor and indomethacin on prostacyclin and thromboxane A2 from ischemic canine heart.
Ogawa K; Sakai K; Ito T; Watanabe J; Satake T
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():371-6. PubMed ID: 6221548
[No Abstract] [Full Text] [Related]
18. Thromboxane-mediated activation of platelets and enhancement of platelet uptake onto collagen-coated glass or deendothelialized rabbit aorta. Comparative effects of a thromboxane antagonist (EPO45) and a thromboxane synthetase inhibitor (dazoxiben).
Menys VC; Davies JA
Lab Invest; 1984 Feb; 50(2):184-9. PubMed ID: 6546403
[TBL] [Abstract][Full Text] [Related]
19. Platelet activating factor involvement in splanchnic artery occlusion shock in rats.
Squadrito F; Sturniolo R; Altavilla D; Santoro G; Campo GM; Arena A; Caputi AP
Eur J Pharmacol; 1991 Jan; 192(1):47-53. PubMed ID: 2040364
[TBL] [Abstract][Full Text] [Related]
20. Increased inotropic state during splanchnic artery occlusion shock in the dog.
Kober PM; Gibbons DA; Raymond RM
Circ Shock; 1987; 21(2):97-110. PubMed ID: 3829331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
